The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis

Xiaolei Pei1,2, Danfeng Zheng1, Shaoping She1

  • 1Department of Immunology, School of Basic Medical Sciences, and Key Laboratory of Medical Immunology of Ministry of Health, Peking University Health Science Center, Beijing, 100191, P.R. China.

Scientific Reports
|July 13, 2017
PubMed

Insights

PC3-secreted microprotein (PSMP) is identified as a key chemokine in ulcerative colitis, driving monocyte migration to inflamed gut tissues. Targeting PSMP offers a novel therapeutic strategy for managing colitis and related inflammatory conditions.

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • Monocytes and macrophages are crucial in colitis pathogenesis.
  • The specific chemokine initiating monocyte migration to colitis tissue is unknown.

Purpose of the Study:

  • To identify the key chemokine responsible for monocyte migration in colitis.
  • To investigate the role of PC3-secreted microprotein (PSMP) in colitis.

Main Methods:

  • Analysis of PSMP expression in human and mouse colitis and tumor tissues.
  • Investigating the effect of PSMP overexpression and anti-PSMP antibodies in DSS-induced colitis models.
  • Assessing PSMP's role in monocyte chemoattraction using chemotaxis and adoptive transfer assays.

Main Results:

  • PSMP is upregulated in colitis tissues and its overexpression exacerbates disease.
  • Anti-PSMP antibodies reduce inflammation by decreasing macrophage infiltration and key cytokine expression (IL-6, TNF-α, CCL2).
  • PSMP chemoattracts monocytes in a CCR2-dependent manner and promotes M1 macrophage CCL2 production.

Conclusions:

  • PSMP is a critical chemokine in ulcerative colitis, mediating monocyte/macrophage recruitment.
  • PSMP represents a novel mechanism influencing gut innate immunity.
  • PSMP is a potential therapeutic target for controlling colitis.